Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
Clinical trial NCT01541202 · TERMINATED
Trial details
- NCT number
- NCT01541202
- Sponsor
- Zensun Sci. & Tech. Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2017-08-01
- Enrollment
- 679
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.